Curis Inc. recently regained compliance with Nasdaq Listing Rule 5550(b)(2) after previously failing to meet the minimum requirements. The company will now be subject to a one-year discretionary monitoring period by the Nasdaq Hearings Panel. During this period, any further non-compliance with Nasdaq listing rules will result in an immediate delisting determination, without an opportunity for Curis to submit a compliance plan or receive an additional cure period. The company would then have to request a new hearing to appeal the delisting decision.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001108205-26-000006), on February 09, 2026, and is solely responsible for the information contained therein.